Fortress Biotech (FBIO) EBITDA Margin (2015 - 2026)
Fortress Biotech (FBIO) reported EBITDA Margin of -47.75% for Q2 2026, up 167.38 percentage points from -215.13% a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) EBITDA Margin (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Fortress Biotech's EBITDA Margin came in at -77.69%, up 91.50 percentage points year-over-year; for FY2025, it was -103.57%, up 80.07 percentage points from FY2024.
- EBITDA Margin has a five-year change of +95.01 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -183.64% in FY2024 (-22.35 pp), -161.29% in FY2023 (+97.71 pp), -259.00% in FY2022 (+7.66 pp) and -266.66% in FY2021 (-68.08 pp).
- Five-year quarterly EBITDA Margin spans a low of -458.23% in Q1 2023 and a high of -22.33% in Q4 2025.
- Year over year, EBITDA Margin gained in four of the last seven quarters, with an average year-over-year change of +45.05 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q3 2023 (a gain of 259.87 percentage points); the low point was Q1 2023 (a drop of 268.00 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 39.16% |
| 10 | Fortress Biotech | 62.31 Mn | -374.25 Mn | 12.58 Mn | -47.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.75% |
| Dec 31, 2025 | -20.22% |
| Sep 30, 2025 | -30.22% |
| Jun 30, 2025 | -212.38% |
| Mar 31, 2025 | -158.54% |
| Dec 31, 2024 | -148.24% |
| Sep 30, 2024 | -142.13% |
| Jun 30, 2024 | -173.32% |
| Mar 31, 2024 | -266.64% |
| Dec 31, 2023 | -89.88% |
| Sep 30, 2023 | -34.21% |
| Jun 30, 2023 | -270.41% |
| Mar 31, 2023 | -453.05% |
| Dec 31, 2022 | -317.20% |
| Sep 30, 2022 | -292.62% |
| Jun 30, 2022 | -266.26% |
| Mar 31, 2022 | -188.61% |
| Dec 31, 2021 | -320.04% |
| Sep 30, 2021 | -226.91% |
| Jun 30, 2021 | -229.34% |
API Access
Fortress Biotech EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();